Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC13A5 | Q86YT5 | 1/20 | 0.46 |
| ▸ | MMP3 | P08254 | 4/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.46 |
| ▸ | MTNR1A | P48039 | 6/20 | 0.45 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.45 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.44 |
| ▸ | MMP2 | P08253 | 3/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.42 |
| ▸ | BAD | Q92934 | 1/20 | 0.42 |
| ▸ | MMP9 | P14780 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7926499 | 0.92 | PTPN1 (0.53) | MMP3AKR1B1MTNR1AMTNR1BPTPN1 | |
| SCHEMBL3476425 | 0.91 | PTPN1 (0.46) | SLC13A5AKR1B1MAOBHCAR2MTNR1A | |
| SCHEMBL7916834 | 0.88 | MAOB (0.52) | SLC13A5MMP3MAOBHCAR2 | |
| SCHEMBL7917889 | 0.82 | MMP12 (0.55) | MMP3AKR1B1MMP2 | |
| SCHEMBL1858161 | 0.81 | KMT2A (0.52) | AKR1B1MTNR1AMCL1 | |
| SCHEMBL1862472 | 0.81 | KMT2A (0.47) | MMP3AKR1B1MTNR1AMMP2MCL1 | |
| SCHEMBL3466501 | 0.80 | HCAR2 (0.52) | SLC13A5MMP3MAOBHCAR2 | |
| SCHEMBL1859538 | 0.80 | MMP12 (0.47) | MMP3MMP2 | |
| SCHEMBL7929539 | 0.79 | MMP2 (0.48) | MMP3AKR1B1MMP2 | |
| SCHEMBL7924568 | 0.79 | MMP12 (0.48) | MMP3AKR1B1MMP2MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010070076-A1 | ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS | CRYSTAX PHARMACEUTICALS, S.L. (ES) | 2010-06-24 | — | — | WO | disclosed |
| WO-2010070076-A1 | ALKANOIC ACID DERIVATIVES AND THEIR THERAPEUTIC USE AS HDAC INHIBITORS | CRYSTAX PHARMACEUTICALS, S.L. (ES) | 2010-06-24 | — | — | WO | disclosed |